JP2006500919A5 - - Google Patents

Download PDF

Info

Publication number
JP2006500919A5
JP2006500919A5 JP2004517500A JP2004517500A JP2006500919A5 JP 2006500919 A5 JP2006500919 A5 JP 2006500919A5 JP 2004517500 A JP2004517500 A JP 2004517500A JP 2004517500 A JP2004517500 A JP 2004517500A JP 2006500919 A5 JP2006500919 A5 JP 2006500919A5
Authority
JP
Japan
Prior art keywords
disease
eczema
crohn
psoriasis
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004517500A
Other languages
English (en)
Other versions
JP2006500919A (ja
JP4511349B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/001983 external-priority patent/WO2004003140A2/en
Publication of JP2006500919A publication Critical patent/JP2006500919A/ja
Publication of JP2006500919A5 publication Critical patent/JP2006500919A5/ja
Application granted granted Critical
Publication of JP4511349B2 publication Critical patent/JP4511349B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (1)

  1. 前記疾患が、
    (a)炎症性腸疾患;
    (b)潰瘍性大腸炎;
    (c)クローン病;
    (d)アトピー性皮膚炎
    (e)湿疹;及び
    )乾癬から成る群からの慢性炎症性疾患である請求項82記載の方法。
JP2004517500A 2002-01-18 2003-01-21 サイトカイン受容体zcytor17マルチマー Expired - Fee Related JP4511349B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35032502P 2002-01-18 2002-01-18
US38910802P 2002-06-14 2002-06-14
US43536102P 2002-12-19 2002-12-19
PCT/US2003/001983 WO2004003140A2 (en) 2002-01-18 2003-01-21 Cytokine receptor zcytor17 multimers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009246276A Division JP2010043120A (ja) 2002-01-18 2009-10-27 サイトカイン受容体zcytor17マルチマー

Publications (3)

Publication Number Publication Date
JP2006500919A JP2006500919A (ja) 2006-01-12
JP2006500919A5 true JP2006500919A5 (ja) 2009-04-02
JP4511349B2 JP4511349B2 (ja) 2010-07-28

Family

ID=30003762

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004517500A Expired - Fee Related JP4511349B2 (ja) 2002-01-18 2003-01-21 サイトカイン受容体zcytor17マルチマー
JP2009246276A Pending JP2010043120A (ja) 2002-01-18 2009-10-27 サイトカイン受容体zcytor17マルチマー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009246276A Pending JP2010043120A (ja) 2002-01-18 2009-10-27 サイトカイン受容体zcytor17マルチマー

Country Status (13)

Country Link
US (24) US7494804B2 (ja)
EP (3) EP2840089A1 (ja)
JP (2) JP4511349B2 (ja)
AT (1) ATE547430T1 (ja)
AU (1) AU2003280410B8 (ja)
CA (1) CA2473733C (ja)
CY (1) CY1112787T1 (ja)
DK (1) DK1576112T3 (ja)
ES (2) ES2382800T3 (ja)
IL (3) IL163067A (ja)
PT (1) PT1576112E (ja)
SI (1) SI1576112T1 (ja)
WO (1) WO2004003140A2 (ja)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2339843T3 (es) 1999-06-02 2010-05-26 Chugai Seiyaku Kabushiki Kaisha Proteina receptora de hematopoyetina novedosa, nr10.
AU7445900A (en) 1999-09-27 2001-04-30 Chugai Seiyaku Kabushiki Kaisha Novel hemopoietin receptor protein, nr12
US20030096339A1 (en) 2000-06-26 2003-05-22 Sprecher Cindy A. Cytokine receptor zcytor17
US9738700B2 (en) 2002-01-18 2017-08-22 Zymogenetics Inc. ZCYTOR17 heterodimeric cytokine receptor
ES2310660T3 (es) 2002-01-18 2009-01-16 Zymogenetics, Inc. Citoquina (ligando zcytor17).
EP2840089A1 (en) 2002-01-18 2015-02-25 ZymoGenetics, Inc. Cytokine receptor zcytor17 multimers
JP2007068402A (ja) * 2003-12-26 2007-03-22 Bml Inc 免疫応答調節蛋白質
CA2580084A1 (en) * 2004-11-03 2006-05-18 Boehringer Ingelheim Pharmaceuticals, Inc. T cell proteins and nucleotides encoding the same
ES2579758T3 (es) * 2005-01-28 2016-08-16 Zymogenetics, Inc. Preparaciones homogéneas de IL-31
AU2006214404B2 (en) 2005-02-14 2012-03-08 Bristol-Myers Squibb Company Methods of treating skin disorders using an IL-31RA antagonist
AU2012202218B2 (en) * 2005-02-14 2014-05-22 National Jewish Medical And Research Center Methods Of Treating Diseases Which Are Mediated By Cutaneous Lymphocyte Antigen Positive Cells
WO2006088956A2 (en) * 2005-02-14 2006-08-24 Zymogenetics, Inc. Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists
CN102321174B (zh) 2005-05-06 2013-10-16 津莫吉尼蒂克斯公司 Il-31单克隆抗体及使用方法
US8101183B2 (en) 2005-05-06 2012-01-24 Zymogentics, Inc. Variable region sequences of IL-31 monoclonal antibodies
US20130216542A1 (en) 2005-05-06 2013-08-22 Zymogenetics, Inc. Variable region sequences of il-31 monoclonal antibodies and methods of use
US7972776B2 (en) 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
MX2008008831A (es) 2006-01-10 2009-03-04 Zymogenetics Inc Metodos para tratar dolor e inflamacion en tejidos neuronales usando antagonistas il-31.
EP3056568B1 (en) * 2006-03-31 2021-09-15 Chugai Seiyaku Kabushiki Kaisha Methods for controlling blood pharmacokinetics of antibodies
KR20150091545A (ko) * 2006-06-08 2015-08-11 추가이 세이야쿠 가부시키가이샤 염증성 질환의 예방 또는 치료제
US7851144B2 (en) 2006-08-18 2010-12-14 The University Of Washington Compositions and methods for detecting cancer
EP2054441A1 (en) * 2006-08-25 2009-05-06 Zymogenetics, Inc. Soluble il-27 receptor
EP2594586B1 (en) * 2006-09-01 2014-08-27 ZymoGenetics, Inc. IL-31 monoclonal antibodies and methods of use
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8278056B2 (en) 2008-06-13 2012-10-02 Oncohealth Corp. Detection of early stages and late stages HPV infection
WO2008086505A2 (en) 2007-01-10 2008-07-17 Zymogenetics, Inc. Methods of using il-31 to treat airway hyper-responsiveness and asthma
CN106519025B (zh) * 2007-09-26 2021-04-23 中外制药株式会社 利用cdr的氨基酸取代来改变抗体等电点的方法
EP3415529B1 (en) * 2007-09-26 2020-11-04 Chugai Seiyaku Kabushiki Kaisha Modified antibody constant region
TW201634479A (zh) * 2007-12-05 2016-10-01 Chugai Pharmaceutical Co Ltd 抗nr10抗體及其應用
MY185647A (en) * 2007-12-05 2021-05-27 Chugai Pharmaceutical Co Ltd Therapeutic agent for pruritus
TR201802202T4 (tr) 2007-12-07 2018-03-21 Merck Serono Sa IL-31'e spesifik beşerileştirilmiş antikor molekülleri.
CA2721052C (en) 2008-04-11 2023-02-21 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
JO3382B1 (ar) * 2008-12-23 2019-03-13 Amgen Inc أجسام مضادة ترتبط مع مستقبل cgrp بشري
EP2409991B1 (en) 2009-03-19 2017-05-03 Chugai Seiyaku Kabushiki Kaisha Antibody constant region variant
TWI682995B (zh) 2009-03-19 2020-01-21 日商中外製藥股份有限公司 抗體恆定區域改變體
TWI654203B (zh) 2010-11-30 2019-03-21 中外製藥股份有限公司 具有鈣依存性的抗原結合能力之抗體
RS60050B1 (sr) 2011-01-18 2020-04-30 Bioniz Llc Kompozicije za modulaciju aktivnosti gama-c-citokina
JP6243521B2 (ja) 2013-05-30 2017-12-06 キニクサ ファーマシューティカルズ, リミテッド オンコスタチンm受容体抗原結合タンパク質
US10464982B2 (en) 2014-04-23 2019-11-05 Emory University Compositions of GM-CSF and interleukin fusions for immune modulation and uses related thereto
US10544227B2 (en) 2015-04-14 2020-01-28 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient
JP5954916B1 (ja) 2015-04-14 2016-07-20 中外製薬株式会社 Il−31アンタゴニストを有効成分として含有する、アトピー性皮膚炎の予防用及び/又は治療用医薬組成物
JP6865737B2 (ja) 2016-03-18 2021-04-28 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. 交換可能なモジュールを備えるモジュール式監視デバイスプラットフォーム
KR20190129077A (ko) 2017-03-15 2019-11-19 팬디온 테라퓨틱스, 인코포레이티드 표적화된 면역관용
MX2019013517A (es) 2017-05-24 2020-08-17 Pandion Operations Inc Inmunotolerancia dirigida.
US10322165B2 (en) * 2017-07-26 2019-06-18 Academia Sinica TIFA antagonists and their use for treating diseases
DK3661954T3 (da) 2017-08-03 2022-04-19 Amgen Inc Interleukin-21-muteiner og fremgangsmåder til behandling
US10174091B1 (en) 2017-12-06 2019-01-08 Pandion Therapeutics, Inc. IL-2 muteins
US10946068B2 (en) 2017-12-06 2021-03-16 Pandion Operations, Inc. IL-2 muteins and uses thereof
MA51631A (fr) 2018-01-12 2020-11-18 Amgen Inc Anticorps anti-pd1 et méthodes de traitement
JP2022533702A (ja) 2019-05-20 2022-07-25 パンディオン・オペレーションズ・インコーポレイテッド MAdCAM標的化免疫寛容
TW202128222A (zh) 2019-11-20 2021-08-01 日商中外製藥股份有限公司 含有抗體之製劑
AU2021297801A1 (en) * 2020-06-24 2023-02-02 Bioniz Therapeutics, Inc. Antagonistic peptide targeting IL-2, IL-9, and IL-15 signaling for the treatment of cytokine-release syndrome and cytokine storm associated disorders
IL300694A (en) 2020-09-01 2023-04-01 Chugai Pharmaceutical Co Ltd A pharmaceutical preparation for the prevention and/or treatment of dialysis pruritus that includes an IL-31 antagonist as an active ingredient

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560472B2 (en) 1981-08-25 1987-04-09 Celltech Limited Yeast expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4603044A (en) 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
CA1280080C (en) 1984-12-06 1991-02-12 Jacques Oberto Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
EP1762623A1 (en) 1988-01-22 2007-03-14 ZymoGenetics, Inc. Methods for producing biologically active peptide dimers
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5124263A (en) 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
WO1992010570A1 (en) 1990-12-13 1992-06-25 Immunex Corporation Leukemia inhibitory factor receptors
JP3202999B2 (ja) 1991-01-31 2001-08-27 協和醗酵工業株式会社 肝移行性リポソーム製剤
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
WO1994006463A1 (en) 1992-09-14 1994-03-31 Pfizer Inc Immortalized cells and uses therefor
WO1995007358A1 (en) 1993-07-30 1995-03-16 University Of Medicine & Dentistry Of New Jersey Efficient gene transfer into primary lymphocytes
CA2169190A1 (en) 1994-02-14 1995-08-17 Richard D. Holly Method for preparing orphan receptor ligands
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
CN1075387C (zh) * 1994-12-29 2001-11-28 中外制药株式会社 含有il-6拮抗剂的抗肿瘤剂的作用增强剂
US6074849A (en) * 1995-07-19 2000-06-13 Genetics Institute, Inc. Polynucleotides encoding human CTLA-8 related proteins
US5965389A (en) 1995-11-09 1999-10-12 Zymogenetics, Inc. Production of GAD65 in methylotrophic yeast
US5792850A (en) 1996-05-23 1998-08-11 Zymogenetics, Inc. Hematopoietic cytokine receptor
AU718510B2 (en) 1996-07-17 2000-04-13 Zymogenetics Inc. Transformation of pichia methanolica
IL128072A0 (en) 1996-07-17 1999-11-30 Zymogenetics Inc Preparation of pichia methanolica auxotrophic mutants
EP2314625B1 (en) 1996-12-03 2014-05-07 Amgen Fremont Inc. Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
GB9819420D0 (en) 1998-09-07 1998-10-28 Glaxo Group Ltd Novel receptor
AU5305300A (en) 1999-06-01 2000-12-18 Schering Corporation Mammalian receptor proteins; related reagents and methods
ES2339843T3 (es) * 1999-06-02 2010-05-26 Chugai Seiyaku Kabushiki Kaisha Proteina receptora de hematopoyetina novedosa, nr10.
CA2389317A1 (en) * 1999-10-20 2001-04-26 Frederic J. De Sauvage Modulation of t cell differentiation for the treatment of t helper cell mediated diseases
AU6531101A (en) 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2004506413A (ja) 2000-06-23 2004-03-04 ジェネンテック・インコーポレーテッド 血管形成に関与する疾患の診断と治療のための組成物と方法
US20030096339A1 (en) * 2000-06-26 2003-05-22 Sprecher Cindy A. Cytokine receptor zcytor17
JP2004501628A (ja) * 2000-06-26 2004-01-22 ザイモジェネティクス,インコーポレイティド サイトカイン受容体zcytor17
CA2425169A1 (en) 2000-10-06 2002-04-11 Immunex Corporation Hematopoietin receptors hpr1 and hpr2
WO2002077230A1 (fr) 2001-03-26 2002-10-03 Chugai Seiyaku Kabushiki Kaisha Variants d'epissage nr10
EP2840089A1 (en) * 2002-01-18 2015-02-25 ZymoGenetics, Inc. Cytokine receptor zcytor17 multimers
ES2310660T3 (es) 2002-01-18 2009-01-16 Zymogenetics, Inc. Citoquina (ligando zcytor17).
WO2003072740A2 (en) * 2002-02-25 2003-09-04 Genentech, Inc. Novel type-1 cytokine receptor glm-r
US7552497B2 (en) * 2002-03-26 2009-06-30 Colgate-Palmolive Company Powered toothbrush with rotating sections
AU2006214404B2 (en) 2005-02-14 2012-03-08 Bristol-Myers Squibb Company Methods of treating skin disorders using an IL-31RA antagonist

Similar Documents

Publication Publication Date Title
JP2006500919A5 (ja)
JP2008540738A5 (ja)
JP2004538039A5 (ja)
JP2006503588A5 (ja)
JP2010538767A5 (ja)
JP2007518723A5 (ja)
NO20053860D0 (no) COP 1 for behandling av inflammatorisk tarmsykdom.
JP2007525988A5 (ja)
JP2006524283A5 (ja)
JP2005526058A5 (ja)
JP2006523595A5 (ja)
JP2009144156A5 (ja)
JP2006501124A5 (ja)
JP2004171519A5 (ja)
JP2007535490A5 (ja)
JP2005515404A5 (ja)
JP2008534513A5 (ja)
JP2007534697A5 (ja)
JP2007520063A5 (ja)
JP2006507484A5 (ja)
JP2007506705A5 (ja)
JP2004269496A5 (ja)
JP2003160581A5 (ja)
JP2005536763A5 (ja)
JP2008514670A5 (ja)